EW Edwards Lifesciences Corporation
As of 3:59:00 PM ET · 50 min old· Couldn’t refresh just now; showing the last price
Loading chart…
- Open
- $98.59
- Previous close
- $95.19
- Day range
- 96.80 – 100.26
- 52-week range
- 74.66 – 100.26
- Volume
- 480.3K
- Avg volume (3M)
- 3.4M
- Market cap
- $53B
- P/E (TTM)
- 56.21
- EPS (TTM)
- $1.68
- Beta
- 0.86
- Dividend yield
- 0.00%
- Next earnings
- Expected Nov 3, 2026 · results pending(estimated from past report dates; not yet confirmed by the company)
- Ex-dividend
- —
- Sector
- Healthcare
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation is a medical technology company focused on structural heart disease and critical care monitoring. Edwards Lifesciences develops and markets transcatheter aortic valve replacement systems, transcatheter mitral and tricuspid therapies, and surgical structural heart products used to repair or replace damaged heart valves. Its portfolio supports minimally invasive procedures designed for patients with advanced cardiovascular conditions, while its monitoring technologies help clinicians assess heart function and fluid status in surgical and intensive care settings. The company serves hospitals, heart centers, and healthcare professionals across major international markets, with products distributed in the United States, Europe, Japan, and other regions. Headquartered in Irvine, California, and founded in 1958, Edwards Lifesciences is recognized for its role in advancing specialized therapies for complex heart disease.
Expected Tue, Nov 3, 2026(estimated from past report dates; not yet confirmed by the company) · results pending
| Quarter | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Jul 23, 2026(after close) | $0.74 | $0.78 | +5.4% |
| Apr 23, 2026(after close) | $0.73 | $0.78 | +6.8% |
| Feb 10, 2026(after close) | $0.62 | $0.58 | −6.5% |
| Nov 4, 2025(after close) | $3.16 | $3.01 | −4.8% |
EW doesn’t pay a dividend.
EW news and filings
Loading filings…
Filings from SEC EDGAR.